Aptevo Therapeutics Inc. — Form D

Aptevo Therapeutics Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-18. The offering totals $2.1M, of which $2.1M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2025-04-18
• Form: D
• Accession: 0001671584-25-000001
• Industry: Pharmaceuticals
• Exemptions: 06c
• Total offering: $2.1M
• Amount sold: $2.1M
• Investors: 11
• Date of first sale: 2025-04-03
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-544060

Issuer

• Name: Aptevo Therapeutics Inc.
• CIK: 0001671584
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 2401 4TH AVE., SEATTLE, WA, 98121
• Phone: 206-838-0500

Officers, directors & promoters (2)

More

• CIK 1671584 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search